Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Ritz

Showing results (301-310 of 315) with videos related to

Pageof 32
Sort By:
Blood|March 15, 2021
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantationLivius Penter, Yi Zhang, Alexandra Savell, et al.
Blood|January 27, 2023
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid diseaseLivius Penter, Yang Liu, Jacquelyn O Wolff, et al.
Nature|July 6, 2017
An immunogenic personal neoantigen vaccine for patients with melanomaPatrick A Ott, Zhuting Hu, Derin B Keskin, et al.
Nature Medicine|April 20, 2026
Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trialOmar Nadeem, David M Cordas Dos Santos, Sarah Nikiforow, et al.
Nature Communications|June 14, 2020
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplantTarek H Mouhieddine, Adam S Sperling, Robert Redd, et al.
The Journal of Clinical Investigation|June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in miceNana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.
Nature|March 16, 2018
Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanomaPatrick A Ott, Zhuting Hu, Derin B Keskin, et al.
Nature Medicine|October 21, 2023
Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
Nature Medicine|December 4, 2023
Author Correction: Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
The New England Journal of Medicine|October 9, 2014
A modified γ-retrovirus vector for X-linked severe combined immunodeficiencySalima Hacein-Bey-Abina, Sung-Yun Pai, H Bobby Gaspar, et al.
Pageof 32

Showing results (301-310 of 315) with videos related to

Sort By:
Pageof 32
Blood|March 15, 2021
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantationLivius Penter, Yi Zhang, Alexandra Savell, et al.
Blood|January 27, 2023
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid diseaseLivius Penter, Yang Liu, Jacquelyn O Wolff, et al.
Nature|July 6, 2017
An immunogenic personal neoantigen vaccine for patients with melanomaPatrick A Ott, Zhuting Hu, Derin B Keskin, et al.
Nature Medicine|April 20, 2026
Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trialOmar Nadeem, David M Cordas Dos Santos, Sarah Nikiforow, et al.
Nature Communications|June 14, 2020
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplantTarek H Mouhieddine, Adam S Sperling, Robert Redd, et al.
The Journal of Clinical Investigation|June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in miceNana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.
Nature|March 16, 2018
Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanomaPatrick A Ott, Zhuting Hu, Derin B Keskin, et al.
Nature Medicine|October 21, 2023
Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
Nature Medicine|December 4, 2023
Author Correction: Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
The New England Journal of Medicine|October 9, 2014
A modified γ-retrovirus vector for X-linked severe combined immunodeficiencySalima Hacein-Bey-Abina, Sung-Yun Pai, H Bobby Gaspar, et al.
Pageof 32